MultimorbidityMULTIPASS-2NCT03697772
Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
An observational study of Multimorbidity and Continuity of Care, run by University of Paris 5 - Rene Descartes at 1 site in France.
Trial summary
Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Multimorbidity, Continuity of Care
- How many people
- 200 participants
- Where
- 1 siteFrance
- Study dates
- 15 Oct 2021to 15 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: multimorbid primary care patients
Who may be able to join
- over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study
Who cannot join
- seen at home
- unable to respond (cognitive problems or language barrier)
Trial locations and contacts
1 site in 1 country.
About this study
Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients
Read the detailed description
The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date.
This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.
- Conditions
- Multimorbidity, Continuity of Care
- Keywords
- continuity of care, primary care, multimorbidity, quality of life
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| multmorbid patients | patients with 2 chronic diseases (medical conditions requiring management for more than 6 months) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Continuity of care
Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)
Measured: over the past 1year
care pathway
the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database
Measured: over the past 1 year
Secondary outcomes (2)
global quality of life
EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)
Measured: over the past 1 year
burden of traitement
Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)
Measured: over the past 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Oct 2018
- Study start15 Oct 2021
- Primary completion15 Dec 2021
- Study completion15 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MultimorbidityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Paris 5 - Rene Descartes
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Alexandre MALMARTEL, University of Paris 5 - Rene Descartes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03697772
- Sponsor's protocol ID
- 2018-A01159-46
- Acronym
- MULTIPASS-2
- Status last verified
- May 2023
- First submitted
- 2 Oct 2018
- Last updated
- 9 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients
- ClinicalTrials.gov ID
- NCT03697772
- Acronym / sponsor ID
- MULTIPASS-2 / 2018-A01159-46
- Conditions
- Multimorbidity, Continuity of Care
- Keywords
- continuity of care, primary care, multimorbidity, quality of life
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- University of Paris 5 - Rene DescartesUniversity, hospital or other
- Study start
- 15 Oct 2021 (actual)
- Primary completion
- 15 Dec 2021 (actual)
- Study completion
- 15 Dec 2022 (actual)
- First posted
- 5 Oct 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients
Detailed description
The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date.
This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| multmorbid patients | – | –patients with 2 chronic diseases (medical conditions requiring management for more than 6 months) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- multimorbid primary care patients
Key inclusion criteria (1 listed)
- over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study
Key exclusion criteria (2 listed)
- seen at home
- unable to respond (cognitive problems or language barrier)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Continuity of care
Time frame: over the past 1year
Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)
care pathway
Time frame: over the past 1 year
the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database
2 secondary outcomes
global quality of life
Time frame: over the past 1 year
burden of traitement
Time frame: over the past 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 May 2023.
- Individual participant dataSharing planned: No
Related trials for Multimorbidity
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
Knee Osteoarthritis, Multimorbidity
Active, not recruiting
Optimizing Prescribing Decisions for Hospitalized Older Adults With Chronic Conditions
Prescribing Decisions, Diabetes
RecruitingObservational study
How Complexity and Multiple Illnesses Affect Hospitalized Patients' Health: A Multicenter Study
Multimorbidities
Not yet recruiting
Cardiovascular Disease Multimorbidity
Cardiovascular Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Multimorbidity and Continuity of Care, run by University of Paris 5 - Rene Descartes at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Continuity of care (time frame: over the past 1year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2023.